We aimed to explore differences in ovarian reserve, measured by AMH levels, between women with MS and healthy controls, and to evaluate the influence of age on NFL and GFAP levels in women with MS of childbearing age. The gene discussed is GFAP; the disease is myeloid sarcoma.